Sarcopenia, the lowered skeletal muscle mass, weakened skeletal muscle strength, and
reduced physical performance with aging, is a component of frailty and high-risk factor for …

Objective Aging causes changes in body composition, in which differences in the distribution
and amount of fat and muscle tissue affect the development of various diseases according to …

Population aging and the obesity epidemic are important global public health problems that
pose an unprecedented threat to the physical and mental health of the elderly and health …

Executive summary Science is key to informing health policy and practice. The coronavirus
(COVID-19) pandemic has brought into the limelight the need to strengthen and …

The COVID-19 pandemics has created unprecedented challenges and threats to patients
and healthcare systems worldwide. Acute respiratory complications that require intensive …

Sarcopenic obesity is of growing research and clinical interest; however, validated
diagnostic criteria are lacking. We therefore aimed to examine the prevalence of sarcopenic …

Background Sarcopenia is defined as age-related low muscle mass and function, and can
also describe the loss of muscle mass in certain medical conditions, such as sarcopenic …

Background: Sarcopenia impairs cardiorespiratory fitness (CRF) in patients with heart failure
with reduced ejection fraction (HFrEF). Obesity has also been shown to impair CRF; …

Purpose This study aimed to investigate the effect of Semaglutide on skeletal muscle and its
metabolomics. Methods A total of 18 male C57BL/6 mice were randomly divided into normal …

Objective We determined the prevalence of sarcopenic obesity in patients with RA using
multiple methods and assessed associations with physical functioning. Methods This study …